| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And President | See Remarks
1 company
Kumar Neil serves as a Chief Executive Officer at BBIO. Across recent SEC filings that breaks down to 0 buys and 216 sells. Those positions are worth an estimated $34.3M at current prices.
Historically, Kumar Neil's trades have earned a below-average insider score of 31/100 across 40 rated trades. Over a 12-month horizon, 9.1% of those trades were profitable, with an average 12-month return of -85.0%.
The biggest single holding is BBIO (~$34.3M) as Chief Executive Officer. The recent filings there lean toward selling, a net 4,118,030 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 120,000 | $14.18 | $1,701,744.00 | -10.6% | +138.0% | +92.6% | |
| Apr 5, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 120,000 | $15.46 | $1,855,656.00 | -9.6% | +12.6% | +81.3% | |
| Mar 3, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 120,000 | $10.96 | $1,315,224.00 | -8.7% | +28.8% | +227.8% | |
| Feb 17, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sale+OE | 44,798 | $12.70 | $569,073.47 | -0.9% | +6.7% | +184.0% | |
| Feb 3, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 120,000 | $11.01 | $1,320,696.00 | -8.0% | +24.3% | +212.2% | |
| Jan 5, 2023 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 120,000 | $7.67 | $920,856.00 | -7.4% | +102.2% | +390.8% | |
| Dec 21, 2022 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 200,000 | $0.00 | - | -16.7% | +63.0% | +369.6% | |
| Nov 17, 2022 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sale+OE | 34,640 | $9.40 | $325,605.61 | -0.7% | +26.4% | +203.1% | |
| Aug 4, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 80,000 | $27.23 | $2,178,066.07 | -3.7% | - | - | |
| Jul 2, 2020 | BBIO Bridgebio Pharma, Inc. | CEO And President | Sell | 143,470 | $30.75 | $4,411,357.06 | -6.2% | - | - |